Evidence map›Paper›PMID 37268620›Full record

ArticleSignal transduction and targeted therapy2023

Murine studies and expressional analyses of human cardiac pericytes reveal novel trajectories of SARS-CoV-2 Spike protein-induced microvascular damage.

Elisa Avolio, Prashant K Srivastava, Jiahui Ji, Michele Carrabba, Christopher T W Tsang, Yue Gu, Anita C Thomas, Kapil Gupta, Imre Berger, Costanza Emanueli and 1 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Signal transduction and targeted therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Elisa Avolio *Bristol Medical School, Translational Health Sciences, University of Bristol, Bristol, UK.ORCID 0000-0003-4801-8480
Prashant K Srivastava *National Heart & Lung Institute, Imperial College, London, UK.
Jiahui JiNational Heart & Lung Institute, Imperial College, London, UK.
Michele CarrabbaBristol Medical School, Translational Health Sciences, University of Bristol, Bristol, UK.
Christopher T W TsangBristol Medical School, Translational Health Sciences, University of Bristol, Bristol, UK.ORCID 0000-0003-3394-6604
Yue GuBristol Medical School, Translational Health Sciences, University of Bristol, Bristol, UK.
Anita C ThomasBristol Medical School, Translational Health Sciences, University of Bristol, Bristol, UK.ORCID 0000-0002-3792-2653
Kapil GuptaSchool of Biochemistry, University of Bristol, Bristol, UK.ORCID 0000-0002-2115-3503
Imre BergerSchool of Biochemistry, University of Bristol, Bristol, UK.
Costanza EmanueliNational Heart & Lung Institute, Imperial College, London, UK.
Paolo MadedduBristol Medical School, Translational Health Sciences, University of Bristol, Bristol, UK. mdprm@bristol.ac.uk.

Funding

British Heart Foundation CH/15/1/31199British Heart Foundation PG/20/10285Department of HealthWellcome Trust 106115/Z/14/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19AnimalsHumansMicePericytesSARS-CoV-2Spike Glycoprotein, CoronavirusSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID37268620
PMCPMC10236384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.